Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 8 de 8
Filtre
Ajouter des filtres








Gamme d'année
2.
Journal of Veterinary Science ; : 25-32, 2005.
Article Dans Anglais | WPRIM | ID: wpr-148130

Résumé

The studies were conducted on Balb/c mice exposed to restraint stress twice for 12 h at 24 h intervals. Prior to restraint stress the mice were treated with sodium diethyldithiocarbamate (DTC) i.p. at a dose of 20 mg/kg five times at 48 h intervals. DTC was used per se or with zinc ions interaction, by adding zinc sulfate to drinking water at a dose of 72 microgram/mouse daily. The results obtained in the study show that restraint stress causes involution of lymphatic organs, decreased the percentage of immature (CD4+CD8+) and, mature (CD4+) thymocytes and CD4+, CD8+and CD19 + splenocytes and proliferative response of thymocytes stimulated in vitro with concanavalin A (Con A) and phytohemagglutinin (PHA). The restraint stress decreased also interleukin-1 (IL-1) production by murine intraperitoneal macrophages stimulated in vitro with lipopolysaccharide (LPS) from E. coli. Pretreatment with DTC counteracted restraint stress-induced immunosuppression, which is expressed as partial normalisation of the total number of thymocytes, splenocytes and IL-1 production, accelerated regeneration of thymus and spleen, shorter suppressive action of restraint stress on the percentage of CD4+CD8+thymocytes and in total normalisation of the CD4+thymocytes and splenocytes. DTC administered prior to restraint stress augmented the proliferative response of thymocytes to two mitogens. The immunocorrecting action of DTC is enhanced by zinc supplementation, expressed in the increased percentage of CD4+thymocytes and splenocytes, CD19 + splenocytes, proliferative activity of thymocytes stimulated with PHA and IL-1 production. The obtained results show that DTC administration can be supplemented with zinc in order to restore the immune system impaired by stress.


Sujets)
Animaux , Femelle , Mâle , Souris , Adjuvants immunologiques/pharmacologie , Acide diéthyl-dithiocarbamique/pharmacologie , Immunité cellulaire/effets des médicaments et des substances chimiques , Interleukine-1/biosynthèse , Macrophages péritonéaux/immunologie , Souris de lignée BALB C , Mitogènes/biosynthèse , Taille d'organe/effets des médicaments et des substances chimiques , Contention physique , Rate/cytologie , Stress physiologique/étiologie , Sous-populations de lymphocytes T/effets des médicaments et des substances chimiques , Thymus (glande)/cytologie , Sulfate de zinc/pharmacologie
3.
Indian J Exp Biol ; 2002 Mar; 40(3): 258-61
Article Dans Anglais | IMSEAR | ID: sea-58634

Résumé

Intraperitoneal injection of rats with diethyldithiocarbamate (1.2 g/kg body wt) led to maximum diminution of superoxide dismutase activity at 1 hr by 86 and 84% in liver and red blood cell respectively with a gradual return to the normal level at 48 hr after administration of injection. Significant inhibition of selenium-dependent glutathione peroxidase was also observed, which returned to normal at 48 hr after administration of injection. However, maximum decline in its activity was at 12 hr by 52 and 73% in liver and red blood cells respectively. No significant difference in tissue level of selenium-independent glutathione peroxidase was observed during time course study after diethyldithiocarbamate administration. It is possible that inhibition of superoxide dismutase by diethyldithiocarbamate leads to accumulation of superoxide anion which in turn inactivates selenium-dependent glutathione peroxidase by its reaction with selenium at the active site of the enzyme.


Sujets)
Animaux , Chélateurs/pharmacologie , Acide diéthyl-dithiocarbamique/pharmacologie , Antienzymes/pharmacologie , Érythrocytes/effets des médicaments et des substances chimiques , Glutathione peroxidase/antagonistes et inhibiteurs , Foie/effets des médicaments et des substances chimiques , Mâle , Rats , Rat Wistar , Sélénium/métabolisme , Superoxide dismutase/antagonistes et inhibiteurs
4.
Rev. cuba. oncol ; 4(1): 117-28, ene.-abr. 1988. tab
Article Dans Espagnol | LILACS | ID: lil-80693

Résumé

El 43GV040 es un producto sintético análogo al dietildetiocarbamato de sodio con perspectiva de uso en la clínica oncológica. Es por ello que se estudiaron sus efectos sobre la línea celular KB así como en algunos modelos in vivo e in vitro en 2 especies de animales (ratas y curiel), sobre el aparato cardiovascular, respiratorio y tracto gastrointestinal. No se observaron efectos directos en ileon y tráquea. A altas concentraciones se encontró un ligero aumento del inotropismo. En el animal intacto, la dosis mayor ensayada produce una ligera disminución de la frecuencia cardíaca y la presión arterial que se recupera. Estos estudios nos señalan la posibilidad de su introducción en el arsenal terapéutico


Sujets)
Cochons d'Inde , Souris , Rats , Animaux , Humains , Mâle , Femelle , Système cardiovasculaire/effets des médicaments et des substances chimiques , Cellules KB/effets des médicaments et des substances chimiques , Système digestif/effets des médicaments et des substances chimiques , Acide diéthyl-dithiocarbamique/pharmacologie , Appareil respiratoire/effets des médicaments et des substances chimiques
SÉLECTION CITATIONS
Détails de la recherche